Richard T. Kenney - Jul 11, 2025 Form 4 Insider Report for Sonnet BioTherapeutics Holdings, Inc. (SONN)

Role
Chief Medical Officer
Signature
/s/ Richard T. Kenney
Stock symbol
SONN
Transactions as of
Jul 11, 2025
Transactions value $
$0
Form type
4
Date filed
7/15/2025, 07:35 PM
Previous filing
Aug 21, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kenney Richard T Chief Medical Officer 100 OVERLOOK CENTER, SUITE 102, PRINCETON, /s/ Richard T. Kenney 2025-07-15 0001606653

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SONN Common Stock Award +8K +582.24% 9.37K Jul 11, 2025 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 11, 2025, the Reporting Person was granted 8,000 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest as to 100% of the restricted stock units on the earlier of (i) January 8, 2026, or (ii) the date of a "Change in Control" (as defined under the Issuer's 2020 Omnibus Equity Incentive Plan).
F2 Includes unvested restricted stock units.
F3 All amounts reflect the Issuer's 1:22 reverse stock split effective as of August 31, 2023 and 1:8 reverse stock split effective as of September 30, 2024.